论文部分内容阅读
目的:探讨血小板增多与食管癌临床病理因素的关系。方法:比较150例食管癌患者及360名正常人血小板水平。血小板计数≥300×109L-1定义为血小板增多。结果:正常人群及食管癌患者血小板水平分别为(204±114)×109L-1和(289±125)×109L-1,血小板增多患者比例与浸润深度(P=0.010)、淋巴结转移(P=0.003)有关。结论:血小板与食管癌发展、转移有关,血小板增多能预测食管癌患者分期及预后。
Objective: To investigate the relationship between thrombocytosis and clinicopathological factors in esophageal cancer. Methods: The platelet levels of 150 esophageal cancer patients and 360 normal subjects were compared. Platelet count ≥300 × 109L-1 is defined as thrombocytosis. Results: The levels of platelet in normal and esophageal cancer patients were (204 ± 114) × 109L-1 and (289 ± 125) × 109L-1, respectively. The proportion of patients with thrombocythemia and the depth of invasion (P = 0.010) 0.003). Conclusion: Platelets and esophageal cancer development, metastasis, thrombocytopenia can predict the stage and prognosis of esophageal cancer patients.